Sodium aurothiomalate - Rheumatoid arthritis
You are here : Home > Formulary Search > Sodium aurothiomalate - Rheumatoid arthritis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
PAD Profile
ChemicalSubstance :
Sodium aurothiomalate
Indication :
Rheumatoid arthritis
Group Name :
Keywords :
GOLD, RA
Brand Names Include :
Myocrisin
Important Information :
Severe disease only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Sodium aurothiomalate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Rheumatoid arthritis.
Committee Recommendations (1)
The Prescribing Clinical Network considers the prescribing of sodium aurothiomalate in rheumatoid arthritis in NEW patients to be RED - specialist ONLY drugs - treatment initiated and continued by specialist clinicians.
Please note:
- For any new patients initiated on sodium aurothiomalate, prescribing should be retained by the specialist.
- For any patients currently taking sodium aurothiomalate in primary care, monitoring should be retained in primary care and requirements should be as described in the current BNF and SPC.
Primary care monitoring requirements for people on sodium aurothiomalate are available from CKS at: https://cks.nice.org.uk/dmards#!scenario:7